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Abstract
Background: Shoulder dysfunction is common and pathology of the rotator cuff tendons and
subacromial bursa are considered to be a major cause of pain and morbidity. Although many
hypotheses exist there is no definitive understanding as to the origin of the pain arising from these
structures. Research investigations from other tendons have placed intra-tendinous neovascularity
as a potential mechanism of pain production. The prevalence of neovascularity in patients with a
clinical diagnosis of rotator cuff tendinopathy is unknown. As such the primary aim of this pilot
study was to investigate if neovascularity could be identified and to determine the prevalence of
neovascularity in the rotator cuff tendons and subacromial bursa in subjects with unilateral
shoulder pain clinically assessed to be rotator cuff tendinopathy. The secondary aims were to
investigate the association between the presence of neovascularity and pain, duration of symptoms,
and, neovascularity and shoulder function.
Methods: Patients with a clinical diagnosis of unilateral rotator cuff tendinopathy referred for a
routine diagnostic ultrasound (US) scan in a major London teaching hospital formed the study
population. At referral patients were provided with an information document. On the day of the
scan (on average, at least one week later) the patients agreeing to participate were taken through
the consent process and underwent an additional clinical examination prior to undergoing a
bilateral grey scale and colour Doppler US examination (symptomatic and asymptomatic shoulder)
using a Philips HDI 5000 Sono CT US machine. The ultrasound scans were performed by one of
two radiologists who recorded their findings and the final assessment was made by a third
radiologist blinded both to the clinical examination and the ultrasound examination. The findings of
the radiologists who performed the scans and the blinded radiologist were compared and any
disagreements were resolved by consensus.
Results: Twenty-six patients agreed to participate and formed the study population. Of these, 6
subjects were not included in the final assessment following the pre-scan clinical investigation. This
is because one subject had complete cessation of symptoms between the time of the referral and
entry into the trial. Another five had developed bilateral shoulder pain during the same period. The
mean age of the 20 subjects forming the study population was 50.2 (range 32-69) years (SD = 10.9)
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subjects included in the formal analysis, 13 subjects (65%) demonstrated neovascularity in the
symptomatic shoulder and 5 subjects (25%) demonstrated neovascularity in the asymptomatic
shoulder. The subject withdrawn due to complete cessation of symptoms was not found to have
neovascularity in either shoulder and of the 5 withdrawn due to bilateral symptoms; two subjects
were found to have signs of bilateral neovascularity, one subject demonstrated neovascularity in
one shoulder and two subjects in neither shoulder.
Conclusions: This study demonstrated that neovascularity does occur in subjects with a clinical
diagnosis of rotator cuff tendinopathy and to a lesser extent in asymptomatic shoulders. In addition,
the findings of this investigation did not identify an association between the presence of
neovascularity; and pain, duration of symptoms or shoulder function. Future research is required
to determine the relevance of these findings.
Background
Musculoskeletal disorders of the shoulder resulting in
pain are very common, and after the 6th decade shoulder
pain appears to be more common than in any other
region[1]. As the shoulder is used to position the hand to
perform functional activities pain in this region is associ-
ated with substantial morbidity. Pathology of the rotator
cuff muscle and tendon as well as pathology involving the
subacromial bursa are considered to be principal causes of
pain[2]. A review of anatomy and function of the rotator
cuff and bursa and pathology involving these structures
has recently been published[3]. Tendinopathy is a generic
term to describe all forms of tendon pathology including
structural changes such as; degeneration, tendinitis, par-
tial and full thickness tears. It is associated with failed
healing[4]. Tendinopathy may also be associated with
biochemical changes[5,6]. In the shoulder rotator cuff
tendinopathy may be associated with subacromial bursal
changes[7].
The aetiology of rotator cuff tendinopathy is uncertain as
is the cause of pain and proposed pathoaetiological fac-
tors have included; intrinsic tendon failure involving both
tendon overload and underload, extrinsic irritation on the
tendon, combinations of both intrinsic and extrinsic fac-
tors, postural variations, nutritional and systemic factors,
evolutionary factors as well as genetics[4,8-14].
The classic pathoaetiological model of tendinopathy is
inflammatory[15]. However this model has been chal-
lenged[16-20], and to a large extent the inflammatory
model has been replaced by a degenerative model to
describe the pathology in overuse tendinopathies, includ-
ing those of the rotator cuff[21,22]. Alternative models
have been proposed that have attempted to stage the
pathology[4,8] as well as to explain the potential reasons
for the pain[19,23,24]. However due to insufficient sub-
ject numbers, poorly designed studies, biopsy and chemi-
cal analysis performed after interventions such as; rest,
electrotherapy modalities, NSAIDs, corticosteroid injec-
tions and rehabilitation, a robust understanding of the
true pathohistology associated with acute through chronic
rotator cuff tendinopathy specifically and other tendin-
opathies generally is profoundly limited, and it may be
too early and presumptuous to abandon the inflamma-
tory model until definitive data are presented. In support
of this, the signs of cells classically associated with inflam-
mation have been reported in small but not large rotator
cuff tears[25] and in the bursal tissue of patients with con-
stant and night pain, but not in patients with pain experi-
enced only on movement[26]. It is highly likely that the
pathoaetiology and pathohistology of rotator cuff tendon
pain and dysfunction are complex and multifactorial, as
well as being time and presentation dependent.
A non inflammatory chemical irritation of the neural tis-
sue associated with tendons has been proposed as a
potential mechanism of pain production
[5,17,18,24,27,28]. The potential for chemical irritation
in rotator cuff tendinopathy is supported by studies that
have demonstrated sensory innervation and the presence
of nociceptive free nerve endings (Aδ and C)  in the sub-
acromial bursa[29-31]. In addition, high concentrations
of chemicals that may stimulate these nociceptors have
been identified in patients with clinical signs of rotator
cuff tendinopathy and subacromial pain syndrome[5,32].
These include; substance P and calcitonin gene-related
peptide[29], the matrix metalloproteinases; MMP1 and
MMP9, the cyclooxygenase (COX) enzymes; Cox-1 and
Cox-2, tenacin-C, and the cytokines; IL-1β, IL-6, TNFα
and vascular endothelial growth factor (VEGF) in the bur-
sal and tendon tissues[5,28,33-36]. A positive correlation
between the concentration of some of these chemicals
and the intensity of pain has been reported[32]. Findings
from animal studies have demonstrated that the combina-
tion of substance P and interleukin-1 leads to the develop-
ment of intense neovascularisation[37]. Neovascularity
associated with tendons is characterised by the formation
of microvascular networks in and around tendon tis-
sue[38,39], and may be associated with neural tissue thatPage 2 of 14
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Colour Doppler ultrasound[38,40,41] and power Dop-
pler ultrasound[39] have been used extensively to identify
neovascularity associated with tendon pathology and
have become an established method based on the princi-
pal that blood flow rates in normal tendon are relatively
low[42]. Power Doppler ultrasound is a well-recognised
and long-established technique for detection of soft tissue
hyperaemia or neovascularisation. Newman et al demon-
strated that power Doppler consistently determines
hyperperfusion associated with musculoskeletal inflam-
matory disorders[43]. This depiction of increased vascu-
larity, ranges from frank tissue blush to isolated new
peritendinous and peribursal vessels. The tissue blush is
thought to represent very small vessels (microvascular
flow)[43].
In the past decade a relationship between neovascularity
and tendon pain has been proposed [38,44-46]. Alfred-
son et al[40] used a combination of clinical assessment
and ultrasonography to compare 25 tendons in 24 people
with painful midsection Achilles tendinopathy, with 20
tendons from 14 subjects without symptoms. Grey scale
ultrasound and colour Doppler ultrasound were used to
respectively investigate the tendon structure and blood
flow within the tendon. Grey scale ultrasound in the sub-
jects without symptoms revealed a normal tendon struc-
ture. Although the study lacked sufficient information on
the source population the reported findings from the 25
symptomatic tendons involved a localised widening of
the tendon, together with irregular fibre structure and
focal hypoechoic areas corresponding with the painful
mid-section of the tendon were identified. In all 25 pain-
ful tendons, neovascularisation was identified in the area
of the grey scale tendon changes. Neovascularisation was
not observed in the 20 pain-free tendons.
Ultrasound utilizes sound waves in the range of greater
than 20,000 Hz normally inaudible to human ears. Ultra-
sound travels in longitudinal waves and when they strike
human tissue produce echoes at tissue interfaces[47].
Although some of the waves get absorbed others are
reflected back to skin where the US probe detects and
processes the waves to construct an anatomic image. For
visualisation of musculoskeletal structures, the most use-
ful frequencies are between 7 and 12 MHz. Ultrasound
utilizes the Doppler Effect, in which the reflected frequen-
cies from an object appear to change as the object travels
toward or away from a reference point. Using this princi-
pal, information regarding blood flow may be
obtained[48]. Colour Doppler ultrasound depicts blood
flow as a colour map superimposed on the gray-scale
image in which the colours represent the direction and
mean velocity of blood flow (i.e. towards or away from
the transducer). Power Doppler displays the integral
strength of the Doppler signal as a single colour and usu-
ally offers no information on direction. It tends to be
more sensitive at demonstrating low volume/velocity
flow, making it possible to visualise small vessels[49].
The identification of neovascularity in painful Achilles,
patellar and lateral elbow tendons and the early but none-
theless encouraging results from treatments directed at the
neovascularity [38,50,51] may offer a potential method of
treating painful tendons once more robust research evi-
dence is available. The prevalence of neovascularity in
patients with a clinical diagnosis of rotator cuff tendinop-
athy is currently unknown. As such the principal aim of
this study was to investigate the prevalence of neovascu-
larity in the rotator cuff tendons in subjects with unilateral
shoulder pain clinically assessed to be rotator cuff tendin-
opathy. Secondary aims included an investigation of the
relationship between neovascularity and (i) pain, (ii)
duration of symptoms, and (iii) shoulder function.
Methods
Study design
The study design was a case series designed to investigate
the prevalence of neovascularity in the rotator cuff and
subacromial bursa in people with a clinical diagnosis of
unilateral rotator cuff tendinopathy.
Ethics
Permission to conduct this study was granted by the
Wandsworth Research Ethics Committee, St George's Uni-
versity of London, London, UK. Research Ethics Commit-
tee reference number: 07/Q0803/1. All subjects signed
witnessed informed consent documents and were aware
of all their rights, including the right to withdraw from the
study at any stage of the investigation.
Setting and data collection
The investigation took place in a dedicated diagnostic
ultrasound clinic in a major acute NHS (National Health
Service) teaching hospital in London, UK. Data collection
took place from July 2007 to March 2009.
Participants
Potential participants included people aged between 30 to
75 years with a diagnosis of unilateral shoulder pain who
were referred to the radiological department by their phys-
ical therapist, orthopaedic surgeon or general medical
practitioner with a special interest in musculoskeletal dis-
orders for a routine diagnostic ultrasound scan of the rota-
tor cuff.
Inclusion/exclusion criteria
Inclusion criteria for the participants were; (i) unilateral
shoulder pain, exacerbated during movement located in
the C4/C5 dermatome, (ii) age range between 30 to 75
years, (iii) pain experienced on flexion and/or abduction,
(iv) pain experienced during the Neer Sign and/orPage 3 of 14
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resisted external rotation and or during the 'full cans' test
and/or the 'empty cans' test, and (vi) passive shoulder
range to be greater than active range. The exclusion criteria
were; (i) the reproduction of shoulder pain during physi-
ological cervical spine movements, (ii) a history of shoul-
der subluxations and/or dislocations, (iii) an injection to
the shoulder in the past 12 months, (iv) physiotherapy,
osteopathic or chiropractic treatment to the shoulder
within the past 12 months, (v) recent or previous shoul-
der girdle fractures, (vi) open wounds or skin infections in
the region of the shoulder, and (vii) concurrent involve-
ment in another research investigation.
Procedure
Potential participants who were being routinely referred
for a diagnostic ultrasound scan of the rotator cuff were
informed of the investigation and if interested in learning
more were provided with a participant information docu-
ment by their referring physical therapist, orthopaedic
surgeon or general medical practitioner. In addition,
potential participants were encouraged to discuss possible
participation with family, friends, healthcare workers and
if so wished with the chief investigator. The design
ensured that those wishing and those not wishing to par-
ticipate, and those fulfilling and not fulfilling the inclu-
sion criteria would receive their scans at the same time
point following referral. Those wishing to participate or
discuss participation in more detail met with the chief
investigator prior to the ultrasound scan. On the day of
the scan, at approximately one hour before the ultrasound
scan was performed, the participant met with the chief
investigator to discuss the study and answer any further
questions. Any potential participant not wanting to partic-
ipate would proceed directly to have their scans. Those
agreeing to participate signed witnessed informed consent
documents. Following this, the chief investigator per-
formed a routine clinical investigation involving;
impingement tests, shoulder range of movement, shoul-
der resisted movement tests and cervical screening proce-
dures, principally to ensure compliance with the inclusion
and exclusion criteria on the day of the ultrasound scan.
In addition to this each participant provided routine
demographic information and completed the Oxford
Shoulder Score[52].
Clinical tests and functional measurements
The following are descriptions and interpretations of the
clinical procedures used to include and exclude the poten-
tial participants.
Neer Sign
The patient is seated and the examiner standing. Scapular
movement is restricted by one of the examiners hands
firmly placed on the scapula. The examiners other hand
forces the patient's arm into shoulder elevation (described
as somewhere between flexion and abduction). A positive
response was pain around the acromion during this
manoeuvre[53].
Hawkin's test
Hawkins and Kennedy[54] described a test that involves
flexion of the humerus to 90° and forcibly internally
rotating the shoulder. A positive response was pain
around the acromion during this manoeuvre.
Resisted abduction 30°
Liu et al [55] reported that the peak abduction moment
for the supraspinatus tendon occurs at 30° of abduction.
A positive clinical response to an isometric contraction at
this point in the range was pain under or lateral to the
acromion.
'Full can' and 'empty can' test
Jobe and Jobe[56] described a supraspinatus test where
the arm is placed at 90° of abduction in neutral rotation
(full can) and resistance to elevation is applied. The shoul-
der is then internally rotated and angled forwards by 30°
so that the thumb faces the floor (empty can) and resist-
ance to elevation is repeated. Increased pain or increased
pain and weakness during the 'empty can' test was posi-
tive.
Shoulder active and passive range of movement
Shoulder flexion (assessed in the sagittal plane performed
with the thumb facing upwards) and abduction (assessed
in the plane of the scapula with the thumb facing
upwards) range were measured actively in both shoulders
and passively (only in the symptomatic shoulder), in
standing. Active movement was measured at the first
point of pain and passive movement, was assessed at the
end range of movement or at the point an increase of pain
did not allow any further movement. Active range was
measured using a gravity dependent inclinometer as has
been described previously[57]. Passive range was not
measured with the inclinometer but was recorded as
equal, less than or more than the active range.
Cervical screening procedure
No clinical test has been documented that conclusively
substantiates the relationship between cervical structures
and shoulder symptoms. In an attempt to exclude cervical
referred shoulder pain, each subject was requested to
actively flex, extend and rotate the cervical spine to the left
and right to the end of their available range to determine
if these movements reproduced the individuals shoulder
pain[58]. If symptoms were produced in the shoulder the
participant would be excluded.
Oxford Shoulder Score
The Oxford Shoulder Score is a validated 12 question
shoulder disability completed independently by the indi-Page 4 of 14
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sents maximal disability and 48 no disability[59].
Ultrasound procedure
Ultrasound of both shoulders was performed using a
Philips HDI 5000 sono CT (Philips Medical Systems, Sur-
rey, UK) with the patient sitting upright and the examiner
scanning from the front. A linear high frequency probe (5-
12 MHz) was used with the musculoskeletal shoulder set-
ting preset with the room darkened to enhance monitor
visualization. The ultrasound scan was performed using a
standard protocol beginning with examination of biceps
tendon in transverse and longitudinal planes with the
patient's forearm or hand resting in a supinated position
on thigh. Following this the acromioclavicular joint was
assessed in the same position. The subscapularis tendon
was then examined with the patients arm externally
rotated. Imaging of supraspinatus tendon was performed
by asking the patient to place the hand in the back pocket
area with the palm facing toward the gluteal muscles
while keeping the elbow directed posteriorly. The
supraspinatus tendon was examined in the transverse and
longitudinal planes. Vascularity was then assessed in both
planes with power Doppler optimized for low flow imag-
ing and a pulse repetition frequency of 700 MHz. The pos-
terior glenohumeral joint, infraspinatus and teres minor
were examined with patient's arm across the chest with
the hand placed on the opposite shoulder.
Blinding of the interpretation of the ultrasound scans
To reduce knowledge of the side of symptoms as a source
of bias, a third radiologist who was not present at the time
of the ultrasound investigation, and was therefore blinded
to the clinical symptoms and side of shoulder pain,
assessed the images for the presence of grey scale changes
and neovascularity. The third radiologist was provided
with the hospital identification number of the partici-
pants and the ultrasound studies were then reviewed on
hospitals digital imaging system without reference to any
clinical details. The anonymization was performed by dis-
abling any clinical information (i.e. request form or
reports) available on the electronic patient archiving and
communication system information window.
After the third radiologist completed the blinded assess-
ment of the ultrasound scans his findings were compared
with the initial reports. It was planned that any uncertain-
ties would be resolved by consensus between the third
radiologist and the two involved in the scanning. This
arbitration process was not required. There was good con-
sensus between the three radiologists in detecting and/or
scoring neovascularisation. This has been reflected in
other studies. Sengkerij et al demonstrated excellent inter-
observer reliability when scoring neovascularisation in
the mid portion of the Achilles tendon[60].
Description of grey scale ultrasound and power Doppler 
neovascularity findings
Grey scale ultrasound appearances of tendinopathy
include swelling of affected tendon and abnormal tendon
echotexture with a heterogeneous hypoechoic appear-
ance[7]. Tendon swelling is interpreted as focal or more
often diffuse increase in tendon thickness. In the case of
the supraspinatus, a difference in tendon thickness of 1.5
to 2.5 mm between the affected and unaffected side or an
absolute thickness of more than 8 mm is thought to indi-
cate tendinopathy[61]. The abnormal echotexture repre-
sent subtle fibrillar tears and area of mucoid degeneration
interspersed with reparative process in tendon substance.
A partial thickness tear is diagnosed on ultrasound when
a true defect or cleft within the tendon substance is
detected in both longitudinal and transverse planes. A full
thickness tear extends from the bursal to articular surface
and associated with other indirect signs[7]. We devised a
simple grading system to describe the amount of neovas-
cularity identified. Grade 0, no neovascularity; Grade I,
mild neovascularity with no recognisable vessels; Grade
II, identifiable vessels involving less than 50% of the area
imaged; and, Grade III, identifiable prominent vessels
involving more than 50% of the area imaged. In addition
to the grade, the location of any observed neovascularity
was also recorded. A positive correlation exists between
tendinopathy and neovascularisation[44,62]. However,
the exact significance of this correlation is yet to be deter-
mined.
Statistical methods
Associations between neovascularity and (i) pain and (ii)
the Oxford Shoulder Score were tested. Fisher's Exact test
was used to test the association with dichotomous meas-
ures. For continuous measures Wilcoxon's test was used.
All tests were two-tailed and statistical significance was set
at p = 0.05.
Sample size calculation
There was a conceptual assumption that the prevalence of
neovascularity would be 0% in the shoulders without
symptoms. This was based on previously published
research[40]. We estimated a prevalence of 30% for the
presence of neovascularity in people with symptomatic
shoulders with a clinical diagnosis of rotator cuff tendin-
opathy. Based upon this hypothesis it was estimated that
20 subjects with unilateral shoulder symptoms would
have a 58% power to show statistical significance.
Results
Twenty-six participants with unilateral shoulder pain who
were consecutively referred for an ultrasound scan and
agreed to participate in the investigation formed the study
population. All referred potential participants were will-
ing to participate in the investigation. The average waitPage 5 of 14
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the scan was at least one week. During this time symp-
toms changed in six participants. This was detected during
the pre-scan clinical evaluation. These changes ranged
from complete cessation of symptoms (one subject) to
development of bilateral pain (five subjects). These six
individuals continued to have an ultrasound scan as
requested by their referring healthcare professional.
Although their ultrasound findings were recorded, the
results of these six people were not included in the main
data analysis as the design of this investigation was to use
the asymptomatic arm as a control. Figure 1 details the
participants' progression into and through the study.
The mean age of the 20 subjects forming the study popu-
lation was 50.2 (range 32-69) years (SD = 10.9) and the
mean duration of symptoms was 22.6 (range .75 to 132)
months (SD = 40.1). Additional demographic and clinical
data for the 20 subjects included in the analysis are
detailed in Table 1.
Fourteen of the 20 subjects had grey scale ultrasound
changes in these tissues in the symptomatic side. Five sub-
jects had grey scale changes in the asymptomatic shoul-
der. Of the 20 subjects included in the formal analysis, a
total of 13 subjects (65%) demonstrated neovascularity in
the symptomatic shoulder and 5 subjects (25%) demon-
strated neovascularity in the asymptomatic shoulder. The
presence and location of any identified neovascularity are
detailed in Table 2.
On the side with symptoms, of the 13 participants with
neovascularity, 6 (46%) demonstrated neovascularity
changes only within the tendon, all involving the superior
aspect of the supraspinatus tendon. Four people (31%)
demonstrated evidence of neovascularity only in the
bursa and 3 (23%) in both the bursa and superior tendon.
Of the twenty subjects with symptoms, 6 were reported to
have a structurally normal supraspinatus tendon on grey
scale imaging and of these 3 (50%) had signs of neovas-
cularity. Of these three, 2 were located in the bursa and 1
in the superior (bursal) aspect of the tendon. Fifteen sub-
jects without symptoms had no structural abnormality
identified in the tendon or bursa. Of the remaining 5
asymptomatic subjects with structural change, 4 (80%)
had evidence of neovascularity either around the bursa or
in the bursal (superior) aspect of the supraspinatus ten-
don.
Of the 13 participants with symptoms and neovascularity,
7 participants were identified as having Grade I neovascu-
larity, 5 with Grade II and one with Grade III. In total
there were 13 participants who reported having constant
pain and of these 8 (62%) presented with signs of neovas-
cularity. Analysis of the data did not suggest an associa-
tion existed between pain presentation (constant/not
constant) and signs of neovascularity (p = 1, Fischer's
Exact test). Both the participant who experienced symp-
toms for the shortest duration (3 weeks) and the one for
the longest period (11 years) had signs of neovascularity
and analysis of the data did not suggest an association
between neovascularity and duration of symptoms (p =
.7, Wilcoxon test). Neovascularity was identified both in
the participant with the worst Oxford Shoulder Score (4/
48) and the best score (45/48). Again, there did not
appear to be an association between the degree of disabil-
ity assessed by the Oxford Shoulder Score and the pres-
ence of neovascularity (p = .6, Wilcoxon test).
The data of six subjects were withdrawn as they did not
comply with the inclusion criteria. One due to complete
cessation of symptoms between the time of being referred
to have a shoulder ultrasound scan and the day of the
scan, and another 5 subjects due to the development of
bilateral symptoms during the same period.
The subject withdrawn due to complete cessation of
symptoms was not found to have neovascularity in either
shoulder and of the 5 withdrawn due to bilateral symp-
toms; two subjects were found to have signs of bilateral
neovascularity, one subject demonstrated neovascularity
in one shoulder and two subjects in neither shoulder.
Information on these 6 subjects is presented in Table 3.
Discussion
In the current investigation, the prevalence of neovascu-
larity within the rotator cuff in participants with unilateral
symptomatic shoulders was found to be 65%. The corre-
sponding prevalence in the asymptomatic shoulders was
25%. This finding suggests that although neovascularity is
more prevalent in the symptomatic shoulder of people
with a clinical diagnosis of rotator cuff tendinopathy it
may also be present in the painfree side. This in agreement
with other studies that have also found a higher preva-
lence of neovascularisation in tendons with symptoms
than those without[39,40,63]. There is however disagree-
ment if neovascularity occurs in painfree tendons. Alfred-
son et al[40] reported a 100% prevalence of
neovascularisation in the Achilles tendon from 25 ten-
dons (24 subjects) with a clinical presentation of mid sec-
tion Achilles tendinopathy and a 0% prevalence in 20
tendons from 14 subjects without symptoms. In contrast,
Cook et al[63] reported that of 26 volleyball players with
abnormal grey scale ultrasound findings and concomitant
neovascularity in the patellar tendons, 15 (58%) had pain
and 11 (42%) did not. This finding suggests that neovas-
cularity may be present in painfree tendons. In addition,
Cook et al[63] reported the absence of neovascularity in
tendons with a normal structural appearance suggesting
that it only occurs together with grey scale ultrasoundPage 6 of 14
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Participant progression through the studyFigure 1
Participant progression through the study.
Referral for diagnostic ultrasound 
scan for people with suspected 
rotator cuff tendinopathy from the 
orthopaedic and physical therapy 
departments and from general 
medical practitioners based in 
primary (community) care. 
(n=26) 
Subjects consenting meeting the 
inclusion and not fulfilling the 
exclusion criteria. 
(n=20) 
Subjects consenting but not meeting the 
inclusion and fulfilling the exclusion criteria at 
the time of the pre-scan clinical assessment. 
(n=6) 
Complete cessation of symptoms (n=1) 
Development of bilateral shoulder pain (n=5) 
Continued to have ultrasound scan 
and data analysed according to 
study design. 
Involvement in study complete. 
(n=20) 
Continued to have ultrasound scan 
and data analysed in secondary 
analysis. 
Involvement in study complete. 
(n=6) 
Returned to referring healthcare 
professional for appropriate 
management following the 
ultrasound scan. 
(n=26) 
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Grey Scale
US findings
Pain-free side
Suprapinatus 
tendon
Painful 
side
Active
movement° 
(passive 
movement)
Pain-free
side
Active 
movement°
NAD F70° (>) Ab85° 
(>)
F140° Ab130°
NAD F54° (>)
Ab55° (>)
F120°
Ab110°
NAD F100° (>)
Ab80° (>)
F160°
Ab160°
NAD F180° (>)
Ab160° (>)
F180°
Ab170°
NAD F80° (>) Ab120° 
(>)
F160° 
Ab160°
Tendinopathy F50° (>)
Ab60° (>)
F165°
Ab170°
NAD F110°
(>) Ab110° (>)
F170°
Ab170°
NAD F120° (>)
Ab110° (>)
F170°
Ab170°
Tendinopathy F160° (>)
Ab140° (>)
F160°
Ab170°
NAD F40° (>)
Ab30° (>)
F170°
Ab170°Table 1: Demographic and clinical information for subjects included in analysis
Subject Age
(years)
Gender Painful
side
Dominant
side
Duration
of symptoms
(months)
Pain
at
rest
OSS
0=worse
48=best
Grey Scale
US findings
Painful side
Suprapinatus 
tendon
1 69 M L R 84 + 22 Tendinopathy
2 52 F L R 4 + 22 Fluid in bursa, 
tendinopathy
3 45 F R R 1.5 + 21 Tendinopathy
or PTT
4 53 F L R 132 - 38 Fluid in bursa,
?calcific 
tendonosis
5 65 F R R 10 + 21 Tendinopathy
6 58 F L L 1 + 22 Tendinopathy
7 56 M R R 8 - 45 PTT-articular
side
8 55 F R R 12 + 22 NAD
(biceps
tendon changes)
9 42 F R R 12 - 39 Tendinopathy
10 57 M R R 36 + 31 NAD
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 and
opathy
NAD F70° (>)
Ab40° (>)
F80°
Ab50°
opathy Tendinopathy F100° (>)
Ab100° (>)
F170°
Ab170°
opathy NAD F95°
(>)
Ab80° (>)
F175°
Ab175°
TT
nd
opathy
NAD F160° (>)
Ab90° (>)
F170°
Ab170°
AD NAD F90° (>)
Ab80° (>)
F170°
Ab170°
opathy
PTT
Tendinopathy F90° (>)
Ab70° (>)
F185°
Ab185°
AD NAD F115° (>)
Ab140° (>)
F180°
Ab180°
opathy Tendinopathy F80° (>)
Ab70° (>)
F180°
Ab180°
AD NAD F70° (>)
Ab40° (>)
F174°
Ab174°
AD NAD F140° (>)
Ab140° (>)
F180°
Ab180°
M cted), PTT (partial thickness tear-supraspinatus), ? (possibly), FTT 
(fu ter than active), < (passive movement less than active), = (passive 
m
Ta11 55 F R R 120 + 4 FTT
tendin
12 64 F L R 0.75 - 34 Tendin
13 45 F L L 1 + 22 Tendin
14 56 M R R 1.5 + 25 F
a
tendin
15 32 F L R 2.5 + 31 N
16 33 M L R 2 - 23 Tendin
or 
17 32 M R R 4 - 25 N
18 38 M R R 6 + 21 Tendin
19 52 M R L 8 + 16 N
20 45 F L R 6 - 28 N
 (male), F (female), L (left), R (right), + (present), - (not present), OSS (Oxford Shoulder Score), NAD (nothing abnormal dete
ll thickness tear), F (flexion), Ab (abduction in the plane of the scapula), ° (degrees of movement), > (passive movement grea
ovement equal to active)
ble 1: Demographic and clinical information for subjects included in analysis (Continued)
BMC Musculoskeletal Disorders 2009, 10:163 http://www.biomedcentral.com/1471-2474/10/163changes. Zanetti et al[39] reported neovascularity in 30 of
55 (55%) painful Achilles tendons and 1 out of 25 (4%)
of asymptomatic tendons. The findings reported by both
Cook et al[63] and Zanetti et al[39] suggest that although
the prevalence of neovascularity is greater in painful ten-
dons it may also occur in painfree tissue. These observa-
tions are supported by the findings of the current
investigation with a 40% higher prevalence of neovascu-
larity occurring in painful tendons. The reasons for the
difference in findings between Cook et al [63], Zanetti et
al [39] and the current study that have all identified neo-
vascularity in painfree tendons and those reported by
Alfredson et al [40] are uncertain. Possible reasons may be
due to methods, age of subjects, difficulty in making a
clinical diagnosis of rotator cuff tendinopathy[64-66] and
possibly differences between upper and lower limb ten-
don loading behaviour and pathology in different popu-
lations. It is possible that the presence of neovascularity
identified in clinically painfree tendons is an indication of
subclinical and emerging pathology. This hypothesis
would need to be tested in an appropriately conducted
longitudinal investigation. It is also possible that neovas-
cularity occurs in an as yet undetermined manner in the
cycle of normal and pathological tendon tissue. However
the higher prevalence of neovascularity in painful lower
limb tendons[39,40,63] and rotator cuff tendons may
indicate that this is an ultrasound sign suggestive of a
painful tendon. It does not appear to be a finding that
may be used in isolation with confidence.
The higher prevalence of neovascularity in painful rotator
cuff tendons found in the current study suggests that 65%
(approximately 2 in 3) patients clinically diagnosed with
rotator cuff tendinopathy may have US signs of neovascu-
larity. This is of potential relevance as pain scores have
been shown to be consistently higher in tendons with
neovascularity when compared with those with-
out[39,63]. Additionally, the presence of neovascularity
may be of relevance as Ohberg and Alfredson[45] hypoth-
esised that the pain in chronic tendinosis may originate
from the new blood vessels and the nerves accompanying
the vessels. Furthermore, they suggested that sclerosing
the neovessels might reduce pain in chronic Achilles tend-
inosis. In a study of 10 subjects with painful Achilles tend-
inosis, colour Doppler ultrasound was used to guide an
injection of a sclerosing agent into the tendon. Ohberg
and Alfredson[45] reported that eight patients were satis-
fied with the results of treatment. There was significantly
reduced pain during activity [reported on a visual ana-
logue scale (VAS)] and no remaining neovascularisation
after an average of two injections. Two patients were not
satisfied, and the neovascularisation was reported to have
remained. At the six month follow up, the same eight
patients remained satisfied and could perform Achilles
tendon loading activities as desired. Their mean VAS
(pain) scores had decreased from 74 before treatment to 8
(p < 0.01), where 100 is maximum and 0 no pain.
More recently, Alfredson and Ohberg[38] conducted a
small randomised double blinded trial that compared the
effect of a sclerosing injection or control injection (lido-
caine and adrenaline) into the area of neovascularity in
painful Achilles tendons. The findings suggested that 5
out of 10 subjects receiving a sclerosing injection reported
satisfaction with treatment, where as none of the 10 sub-
jects randomised to receive the control injection reported
treatment satisfaction. At the 3 month follow-up neovas-
cularisation was absent in all the painfree tendons. This
was not the case for the tendons remaining symptomatic.
The sclerosing agent used in this study was polidocanol,
which has been widely used in the treatment of varicose
veins in the legs and oesophagus, telangiectasia (spider
veins), haemorrhoids and gastroduodenal lesions[67-69].
The emerging literature suggests that neovascularisation
in the patellar and Achilles tendons may be a potential
source of symptoms and elimination of this may help to
reduce the expression of pain. The finding that neovascu-
larity occurs in clinically symptom free lower and upper
limb tendons, suggests that the relationship is not defini-
tive.
Limitations
In this study as well as in others [39,63], neovascularity
was found in asymptomatic tendons. In the study
reported by Alfredson et al[40] no evidence of neovascu-
larity was found in asymptomatic subjects. Alfredson et
al[40] used a population of asymptomatic people as the
control group whereas in the current study the asympto-
matic shoulder served as a reference population. It may be
that neovascularity when present in one region has a sys-
temic effect on other regions of the same individual and
as such a group of age, gender and activity matched
asymptomatic subjects may have been more appropriate.
Although, the findings from the current investigation
were based on a small study population a clear difference
in the expression of neovascularity was identified between
the symptomatic and asymptomatic shoulders. Due to the
anatomical proximity of the subacromial bursa and the
superficial tendon a level of uncertainty exists as to the
actual location of the neovessels. There is also a degree of
uncertainty as to the reliability of the ultrasound report-
ing. Future research needs to determine the intra and inter
tester reliability of both performing and analysing the
ultrasound scans. Additional imaging, histological and
biochemical studies are necessary to determine the exact
locations of the neovessels. The amount of stretch placed
on the tendons and the amount of pressure applied by the
ultrasound transducer were not controlled for. Both these
variables may affect the findings and efforts should bePage 10 of 14
(page number not for citation purposes)
BMC Musculoskeletal Disorders 2009, 10:163 http://www.biomedcentral.com/1471-2474/10/163made in future studies to standardise the ultrasound tech-
nique to reduce the potential impact that these factors
may have on results.
Exercise, in the form of 2 sets of 20 repetitions of shoulder
elevation in the plane of the scapula with a 2.3 kg (5
pound) weight in 31 asymptomatic volunteers (mean age
41 years) significantly increased intra and peritendinous
vascularity in the supraspinatus tendon[70]. The amount
of activity prior to the ultrasound scan in the current study
was not controlled for and although all participants
waited for approximately 30 to one hour minutes prior to
the scan, and no participant participated in exercise dur-
ing this period, it is possible that carrying bags, coats and
jackets prior to the scan influenced the findings. This var-
Table 2: Power Doppler ultrasound findings and presence, location and grade of neovascularity
Subject Neovascularity present 
painful side
Location Grade Neovascularity present 
pain-free side
Location Grade
1 - - - -
2 + peribursal and 
superficial tendon
I - -
3 + peribursal and 
superficial tendon
II - -
4 + superficial tendon II - -
5 + superficial tendon II - -
6 + peribursal and 
superficial tendon
II + superficial tendon II
7 + throughout tendon,
mainly superficially
III - -
8 - - - -
9 + peribursal I + peribursal I
10 + peribursal I - -
11 + peribursal I + peribursal I
12 + superficial tendon II + superficial tendon I
13 - - - -
14 + superficial tendon I - -
15 - - - -
16 - - + superficial tendon I
17 - - - -
18 - - - -
19 + peribursal I - -
20 + superficial tendon I - -
+ (present), - (not present), Grade I (mild neovascularity with no recognisable vessels), Grade II (identifiable vessels involving less than 50% of the 
area imaged), Grade III (identifiable prominent vessels involving more than 50% of the area imaged)Page 11 of 14
(page number not for citation purposes)
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Table 3: Demographic and clinical information for subjects not included in the main analysis
Subject Age
(years)
Gender Painful 
side
Dominant 
side
Duration 
of 
symptoms
Pain 
at 
rest
OSS 
most 
painful 
Grey 
Scale US 
findings 
Painful 
side 
Neovasc 
present
Location Grade Grey 
Scale US
findings 
Painful 
side 
Neovasc 
present
 
(months)
0 = worse
48 = best
Right
s.pinatus 
tendon
Painful 
side 
Right
Left 
s. spinatus 
tendon
Painful 
side 
Left
21 43 M - R 120 - 33 NAD - NAD -
22 53 M B R 36 + 20 Tendinopa
thy
+ Superficial
tendon
I Tendinopat
hy
+ Superficial 
tendon
I
23 68 M B R 3 + 24 Calcific 
tendinosis
- Tendinopat
hy
+ Superficial 
tendon
I
24 69 M B R 4.5 - 18 Tendinopa
thy
+ Superficial 
tendon
I Calcific 
tendinosis 
and 
tendinop
+ Superficial 
and deep 
tendon
II
25 58 M B R 12 - 18 Calcific 
tendinosis 
and 
tendinop
- Calcific 
tendinosis 
and FTT
-
26 61 M B L 12 + 24 NAD - FTT 
Tendinopat
hy
-
M (male), F (female), L (left), R (right), + (present), - (not present), OSS (Oxford Shoulder Score), s.spinatus (supraspinatus), neovasc (neovascularity), NAD (nothing abnormal detected), 
Tendinop (tendinopathy), PTT (partial thickness tear-supraspinatus), FTT (full thickness tear), B (bilateral), Grade I (mild neovascularity with no recognisable vessels), Grade II (identifiable vessels 
involving less than 50% of the area imaged).
BMC Musculoskeletal Disorders 2009, 10:163 http://www.biomedcentral.com/1471-2474/10/163iable would need to be investigated to determine its influ-
ence in future research.
Conclusion
Although other studies have demonstrated the intertester
reliability to detect neovascularity in the Achilles tendon
using power Doppler ultrasonography[60] this was not
investigated in this study. This is a limitation and ques-
tions the accuracy of the reported prevalence of neovascu-
larity reported in the current study. Respecting this
limitation, the findings of this study suggest that neovas-
cularity occurs in subjects with a clinical diagnosis of rota-
tor cuff tendinopathy and to a lesser extent in the
asymptomatic shoulder of the same individual. As neo-
vascularity may exist in asymptomatic shoulders caution
is necessary when reasoning the potential cause and
appropriate therapeutic management for an individual.
Future research needs to establish; the reliability of the
procedure, as well as the relationship and timing of neo-
vascularity and symptoms as well as any correlation
between the reduction of neovascularity and pain relief.
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